| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |